Regarding the proportion of patients with leukocytosis > 13 G/L, anemia with Hb < 10 g/dl, and thrombocytopenia with platelet values < 100 G/L, there was no significant difference between CBL-mutated and nonmutated patients in either cohort. The gene discussed is GSTM1; the disease is anemia.